Integrins and T cell-mediated immunity

Annual Review of Immunology

Volumn 22, Issue , 2004, Pages 157-180

  Pribila, Jonathan T ^a   Quale, Angie C ^a   Mueller, Kristen L ^a   Shimizu, Yoji ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Chemokine; Dendritic cell; Extracellular matrix; Immunological synapse; Signal transduction

Indexed keywords

ALPHA4BETA7 INTEGRIN; ALPHAEBETA7 INTEGRIN; BIOCHEMICAL MARKER; INTEGRIN; INTEGRIN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; CELL MIGRATION; CELL MOTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; DENDRITIC CELL; EFFECTOR CELL; ENDOTHELIUM; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE RECIRCULATION; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL COMMUNICATION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNITY, CELLULAR; INTEGRINS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 2542504572     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104649     Document Type: Review

References (150)

1. Shimizu Y, Rose DM, Ginsberg MH. 1999. Integrins and the immune response. Adv. Immunol. 72:325-80
2. Hynes RO. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110:673-87
3. Lasky LA, Singer MS, Dowbenko D, Imai Y, Henzel WJ, et al. 1992. An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 69:927-38
4. Chen C, Mobley JL, Dwir O, Shimron F, Grabovsky V, et al. 1998. High affinity very late antigen-4 subsets expressed on T cells are mandatory for chemokine-independent adhesion strengthening but not for rolling on VCAM-1 in shear flow. J. Immunol. 162:1084-95
5. Grabovsky V, Feigelson S, Chen C, Bleijs DA, Peled A, et al. 2000. Subsecond induction of α4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J. Exp. Med. 192:495-505
6. Berlin C, Bargatze RF, Campbell JJ, Von Andrian UH, Szabo MC, et al. 1995. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-22
7. Steeber DA, Campbell MA, Basit A, Ley K, Tedder TF. 1998. Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc. Natl. Acad. Sci. USA 95:7562-67
8. Sigal A, Bleijs DA, Grabovsky V, Van Vliet SJ, Dwir O, et al. 2000. The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological sheer flow in a permissive cellular environment. J. Immunol. 165:442-52
9. Salas A, Shimaoka M, Chen SQ, Carman CV, Springer T. 2002. Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin lymphocyte function-associated antigen-1. J. Biol. Chem. 277:50255-62
10. Kadono T, Venturi GM, Steeber DA, Tedder TF. 2002. Leukocyte rolling velocities and migration are optimized by cooperative L-selectin and intercellular adhesion molecule-1 functions. J. Immunol. 169:4542-50
11. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279:381-84
12. Chan JR, Hyduk SJ, Cybulsky MI. 2001. Chemoattractants induce a rapid and transient upregulation of monocyte α4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J. Exp. Med. 193:1149-58
13. Constantin G, Majeed M, Giagulli C, Piccio L, Kim JY, et al. 2000. Chemokines trigger immediate β2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759-69
14. van Kooyk Y, Figdor CG. 2000. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr. Opin. Cell Biol. 12:542-47
15. 4 integrin avidity but not of leukocyte function-associated antigen-1 avidity to endothelial ligands under shear flow requires cholesterol membrane rafts. J. Biol. Chem. 277:40027-35
16. Hwang ST, Singer MS, Giblin PA, Yednock TA, Bacon KB, et al. 1996. GlyCAM-1, a physiologic ligand for L-selectin, activates β2 integrins on naive peripheral lymphocytes. J. Exp. Med. 184:1343-48
17. 1 governs lymphocyte migration. J. Immunol. 167:2824-30
18. 2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinase-2. J. Immunol. 170:5912-18
19. + T cells. J. Exp. Med. 197:643-56
20. Muller WA. 2003. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24:326-33
21. Kavanaugh AF, Lightfoot E, Lipsky PE, Oppenheimer-Marks N. 1991. Role of CD11/CD18 in adhesion and transendothelial migration of T cells: analysis utilizing CD18-deficient T cell clones. J. Immunol. 146:4149-56
22. Ding ZQ, Xiong K, Issekutz TB. 2001. Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA-4 in addition to LFA-1. J. Leukoc. Biol. 69:458-66
23. 2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3:151-58
24. Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA. 2002. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3:143-50
25. Kaldjian EP, Gretz JE, Anderson AO, Shi Y, Shaw S. 2001. Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. Int. Immunol. 13:1243-53
26. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. 2000. Lymphborne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192:1425-39
27. Miyata K, Takaya K. 1981. Elastic fibers associated with collagenous fibrils surrounded by reticular cells in lymph nodes of the rat as revealed by electron microscopy after orcein staining. Cell Tissue Res. 220:445-48
28. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, et al. 2003. Distinct dendritic cell populations sequentially present a subcutaneous antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19:47-57
29. Deleted in proof
30. Karttunen T, Alavaikko M, Apaja-Sarkkinen M, Autio-Harmainen H. 1986. Distribution of basement membrane laminin and type IV collagen in human reactive lymph nodes. Histopathology 10:841-49
31. Ocklind G, Talts J, Fassler R, Mattsson A, Ekblom P. 1993. Expression of tenascin in developing and adult mouse lymphoid organs. J. Histochem. Cytochem. 41:1163-69
32. Hayakawa M, Kobayashi M, Hoshino T. 1988. Direct contact between reticular fibers and migratory cells in the paracortex of mouse lymph nodes: a morphological and quantitative study. Arch. Histol. Cytol. 51:233-40
33. Miller MJ, Wei SH, Parker I, Cahalan MD. 2002. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296:1869-73
34. Stoll S, Delon J, Brotz TM, Germain RN. 2002. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296:1873-76
35. Miller MJ, Wei SH, Cahalan MD, Parker I. 2003. Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc. Natl. Acad. Sci. USA 100:2604-9
36. Bousso P, Robey E. 2003. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4:579-85
37. Dustin ML, Springer TA. 1989. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619-24
38. van Kooyk Y, van de Wiel-van Kemenade P, Weder P, Kuijpers TW, Figdor CG. 1989. Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 342:811-13
39. Morgan MM, Labno CM, van Seventer GA, Denny MF, Straus DB, Burkhardt JK. 2001. Superantigen-induced T cell:B cell conjugation is mediated by LFA-1 and requires signaling through Lck, but not ZAP-70. J. Immunol. 167:5708-18
40. Bromley SK, Dustin ML. 2002. Stimulation of naive T-cell adhesion and immunological synapse formation by chemokine-dependent and -independent mechanisms. Immunology 106:289-98
41. Stefanova I, Dorfman JR, Germain RN. 2002. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature 420:429-34
42. Revy P, Sospedra M, Barbour B, Trautmann A. 2001. Functional antigen-independent synapses formed between T cells and dendritic cells. Nat. Immunol. 2:925-31
43. 2+-dependent protease, calpain. J. Cell Biol. 140:699-707
44. van Kooyk Y, Geijtenbeek TB. 2002. A novel adhesion pathway that regulates dendritic cell trafficking and T cell interactions. Immunol. Rev. 186:47-56
45. Monks CRF, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395:82-86
46. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, et al. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285:221-27
47. Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM, Shaw AS. 2002. T cell receptor signaling precedes immunological synapse formation. Science 295:1539-42
48. Freiberg BA, Kupfer H, Maslanik W, Delli J, Kappler J, et al. 2002. Staging and resetting T cell activation in SMACs. Nat. Immunol. 3:911-17
49. Iezzi G, Karjalainen K, Lanzavecchia A. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89-95
50. Huang JY, Lo PF, Zal T, Gascoigne NRJ, Smith BA, et al. 2002. CD28 plays a critical role in the segregation of PKCθ within the immunologic synapse. Proc. Natl. Acad. Sci. USA 99:9369-73
51. van Stipdonk MJ, Lemmens EE, Schoenberger SP. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:423-29
52. Cyster JG, Shotton DM, Williams AF. 1991. The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J. 10:893-902
53. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-41
54. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, et al. 1996. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274:209-19
55. Takagi J, Petre BM, Walz T, Springer TA. 2002. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110:599-611
56. Xiong JP, Stehle T, Diefenbach B, Zhang RG, Dunker R, et al. 2001. Crystal structure of the extracellular segment of integrin αVβ3. Science 294:339-45
57. Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, et al. 2002. Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand. Science 296:151-55
58. Shimaoka M, Xiao T, Liu JH, Yang YT, Dong YC, et al. 2003. Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112:99-111
59. van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579-86
60. Shimizu Y, van Seventer GA, Horgan KJ, Shaw S. 1990. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J. Immunol. 145:59-67
61. Abraham C, Miller J. 2001. Molecular mechanisms of IL-2 gene regulation following costimulation through LFA-1. J. Immunol. 167:5193-201
62. Ni HT, Deeths MJ, Mescher MF. 2001. LFA-1-mediated costimulation of CD8+ T cell proliferation requires phosphatidylinositol 3-kinase activity. J. Immunol. 166:6523-29
63. Bianchi E, Denti S, Granata A, Bossi G, Geginat J, et al. 2000. Integrin LFA-1 interacts with the transcriptional coactivator JAB1 to modulate AP-1 activity. Nature 404:617-18
64. Leitinger B, Hogg N. 2002. The involvement of lipid rafts in the regulation of integrin function. J. Cell Sci. 115:963-72
65. Horejsi V. 2003. The roles of membrane microdomains (rafts) in T cell activation. Immunol. Rev. 191:148-64
66. fyn. J. Immunol. 159:4806-14
67. Hunter AJ, Ottoson NC, Boerth N, Koretzky GA, Shimizu Y. 2000. Cutting edge: a novel function for the SLAP-130/FYB adapter protein in β1 integrin signaling and T lymphocyte migration. J. Immunol. 164:1143-47
68. Uemura N, Salgia R, Ewaniuk DS, Little MT, Griffin JD. 1999. Involvement of the adapter protein CRKL in integrin-mediated adhesion. Oncogene 18:3343-53
69. Li LM, Guris DL, Okura M, Imamoto A. 2003. Translocation of CrkL to focal adhesions mediates integrin-induced migration downstream of src family kinases. Mol. Cell. Biol. 23:2883-92
70. Peterson EJ, Woods ML, Dmowski SA, Derimanov G, Jordan MS, et al. 2001. Coupling of the TCR to integrin activation by SLAP-130/Fyb. Science 293:2263-65
71. Griffiths EK, Krawczyk C, Kong YY, Raab M, Hyduk SJ, et al. 2001. Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science 293:2260-63
72. Raab M, Kang H, Da Silva A, Zhu XC, Rudd CE. 1999. FYN-T-FYB-SLP-76 interactions define a T-cell receptor ζ/CD3-mediated tyrosine phosphorylation pathway that up-regulates interleukin 2 transcription in T-cells. J. Biol. Chem. 274:21170-79
73. FAK) in PHA-activated T cells. Cell. Immunol. 193:179-84
74. 1 integrin-dependent T cell migration through an HEF1 effector pathway. Eur. J. Immunol. 31:1417-27
75. 1 integrin-mediated costimulation in human T cells. J. Immunol. 163:563-68
76. Dustin ML, Bromley SK, Kan ZY, Peterson DA, Unanue ER. 1997. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc. Natl. Acad. Sci. USA 94:3909-13
77. 1 integrin activation epitopes in T cells: relationship to T cell adhesion and migration. Eur. J. Immunol. 30:38-49
78. Kane LP, Lin J, Weiss A. 2000. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12:242-49
79. Fagerholm S, Hilden TJ, Gahmberg CG. 2002. Lck tyrosine kinase is important for activation of the CD11a/CD18-integrins in human T lymphocytes. Eur. J. Immunol. 32:1670-78
80. Woods ML, Kivens WJ, Adelsman MA, Qiu Y, August A, Shimizu Y. 2001. A novel function for the Tec family tyrosine kinase Itk in activation of β1 integrins by the T cell receptor. EMBO J. 20:1232-44
81. Epler JA, Liu R, Chung H, Ottoson NC, Shimizu Y. 2000. Regulation of β1 integrin-mediated adhesion by T cell receptor signaling involves ZAP-70 but differs from signaling events that regulate transcriptional activity. J. Immunol. 165:4941-49
82. Krawczyk C, Oliveira-dos-Santos A, Sasaki T, Griffiths E, Ohashi PS, et al. 2002. Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity 16:331-43
83. Wells AD, Liu QH, Hondowicz B, Zhang JD, Turka LA, Freedman BD. 2003. Regulation of T cell activation and tolerance by phospholipase Cγ-1-dependent integrin avidity modulation. J. Immunol. 170:4127-33
84. Kucik DF, Dustin ML, Miller JM, Brown EJ. 1996. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J. Clin. Invest. 97:2139-14
85. Katagiri K, Hattori M, Minato N, Irie S, Takatsu K, Kinashi T. 2000. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol. Cell. Biol. 20:1956-69
86. Mobley JL, Ennis E, Shimizu Y. 1994. Differential activation-dependent regulation of integrin function in cultured human T-leukemic cell lines. Blood 83:1039-50
87. Musci MA, Hendricks-Taylor LR, Motto DG, Paskind M, Kamens J, et al. 1997. Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J. Biol. Chem. 272:11674-77
88. Da Silva AJ, Li ZW, De Vera C, Canto E, Findell P, Rudd CE. 1997. Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. Proc. Natl. Acad. Sci. USA 94:7493-98
89. Krause M, Sechi AS, Konradt M, Monner D, Gertler FB, Wehland J. 2000. Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator- stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J. Cell Biol. 149:181-94
90. Wang H, Moon EY, Azouz A, Wu X, Smith A, et al. 2003. SKAP-55 regulates integrin adhesion and formation of T cell-APC conjugates. Nat. Immunol. 4:366-74
91. Ardouin L, Bracke M, Mathiot A, Pagakis SN, Norton T, et al. 2003. Vav1 transduces TCR signals required for LFA-1 function and cell polarization at the immunological synapse. Eur. J. Immunol. 33:790-97
92. Bustelo XR. 2000. Regulatory and signaling properties of the Vav family. Mol. Cell. Biol. 20:1461-77
93. D'Souza-Schorey C, Boettner B, Van Aelst L. 1998. Rac regulates integrin-mediated spreading and increased adhesion of T lymphocytes. Mol. Cell. Biol. 18:3936-46
94. Shimonaka M, Katagiri K, Nakayama T, Fujita N, Tsuruo T, et al. 2003. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J. Cell Biol. 161:417-27
95. Gomez M, Kioussis D, Cantrell DA. 2001. The GTPase Rac-1 controls cell fate in the thymus by diverting thymocytes from positive to negative selection. Immunity 15:703-13
96. Corre I, Gomez M, Vielkind S, Cantrell DA. 2001. Analysis of thymocyte development reveals that the GTPase RhoA is a positive regulator of T cell receptor responses in vivo. J. Exp. Med. 194:903-13
97. Rodríguez-Fernández JL, Sánchez-Martín L, Rey M, Vicente-Manzanares M, Narumiya S, et al. 2001. Rho and Rho-associated kinase modulate the tyrosine kinase PYK2 in T-cells through regulation of the activity of the integrin LFA-1. J. Biol Chem. 276:40518-27
98. Bos JL, De Rooij J, Reedquist KA. 2001. Rap1 signalling: adhering to new models. Nat. Rev. Mol. Cell Biol. 2:369-77
99. Sebzda E, Bracke M, Tugal T, Hogg N, Cantrell DA. 2002. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat. Immunol. 3:251-58
100. Zhang W, Shao Y, Fang D, Huang J, Jeon MS, Liu YC. 2003. Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J. Biol. Chem. 278:23978-83
101. Katagiri K, Hattori M, Minato N, Kinashi T. 2002. Rap1 functions as a key regulator of T-cell antigen-presenting cell interactions and modulates T-cell responses. Mol. Cell. Biol. 22:1001-15
102. Reedquist KA, Ross E, Koop EA, Wolthuis RM, Zwartkruis FJ, et al. 2000. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 148:1151-58
103. Tsukamoto N, Hattori M, Yang HL, Bos JL, Minato N. 1999. Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J. Biol. Chem. 274:18463-69
104. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM. 1997. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 278:124-28
105. 1 integrin-dependent leukocyte adhesion. J. Biol. Chem. 277:40893-900
106. 2+- and antibody-induced LFA-1- and VLA-4-mediated cell adhesion. J. Biol. Chem. 277:29468-76
107. Katagiri K, Maeda A, Shimonaka M, Kinashi T. 2003. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 4:741-48
108. Li RH, Mitra N, Gratkowski H, Vilaire G, Litvinov R, et al. 2003. Activation of integrin αIIbβ3 by modulation of transmembrane helix associations. Science 300:795-98
109. Weljie AM, Hwang PM, Vogel HJ. 2002. Solution structures of the cytoplasmic tail complex from platelet integrin αIIb-β3-subunits. Proc. Natl. Acad. Sci. USA 99:5878-83
110. 3 "inside-out" activation as regulated by its cytoplasmic face. Cell 110:587-97
111. Hughes PE, Diaz-Gonzalez F, Leong L, Wu CY, McDonald JA, et al. 1996. Breaking the integrin hinge - a defined structural constraint regulates integrin signaling. J. Biol. Chem. 271:6571-74
112. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. 1999. The talin head domain binds to integrin β subunit cytoplasmic tails and regulates integrin activation. J. Biol. Chem. 274:28071-74
113. Calderwood DA, Yan B, De Pereda JM, Alvarez BG, Fujioka Y, et al. 2002. The phosphotyrosine binding-like domain of talin activates integrins. J. Biol. Chem. 277:21749-58
114. Lu CF, Takagi J, Springer TA. 2001. Association of the membrane proximal regions of the α and β subunit cytoplasmic domains constrains an integrin in the inactive state. J. Biol. Chem. 276:14642-48
115. 7 integrins and memory differentiation. J. Immunol. 156:3727-36
116. + memory T cells with hallmarks of gut-trophism. J. Immunol. 151:717-29
117. Erle DJ, Briskin MJ, Butcher EC, Garcia-Pardo A, Lazarovits AI, Tidswell M. 1994. Expression and function of the MAdCAM-1 receptor, integrin α4β7, on human leukocytes. J. Immunol. 153:517-28
118. Nakache M, Berg EL, Streeter PR, Butcher EC. 1989. The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes. Nature 337:179-81
119. Bargatze RF, Jutila MA, Butcher EC. 1995. Distinct roles of L-selectin and integrin α4β7 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity 3:99-108
120. + T cells activated in cutaneous or mucosal lymphoid tissues. J. Exp. Med. 195:135-41
121. Stagg AJ, Kamm MA, Knight SC. 2002. Intestinal dendritic cells increase T cell expression of α4β7 integrin. Eur. J. Immunol. 32:1445-54
122. Eβ7 mediates adhesion of T lymphocytes to epithelial cells. J. Immunol. 150:3459-70
123. 7 integrins on thymocytes, intestinal epithelial lymphocytes and peripheral lymphocytes. Eur. J. Immunol. 26:897-905
124. 7 with E-cadherin. J. Cell Biol. 140:197-210
125. 7- requirement for cadherin dimerization and implications for cadherin and integrin function. J. Biol. Chem. 276:30862-70
126. 7-containing integrin defined by HML-1 monoclonal antibody. Eur. J. Immunol. 22:2887-92
127. E (CD103)-deficient mice. J. Immunol. 162:6641-49
128. Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, et al. 2002. Expression of the integrin αEβ7 identifies unique subsets of CD25+ as well as CD25-regulatory T cells. Proc. Natl. Acad. Sci. USA 99:13031-36
129. Ludviksson BR, Strober W, Nishikomori R, Hasan SK, Ehrhardt RO. 1999. Administration of mAb against αEβ7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice. J. Immunol. 162:4975-82
130. E (CD103)-deficient mice. J. Immunol. 165:6583-89
131. Hemler ME. 1990. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:365-400
132. Krivacic KA, Levine AD. 2003. Extracellular matrix conditions T cells for adhesion to tissue interstitium. J. Immunol. 170:5034-44
133. Bank I, Koltakov A, Goldstein I, Chess L. 2002. Lymphocytes expressing α1β1 integrin (very late antigen-1) in peripheral blood of patients with arthritis are a subset of CD45RO(+) T-cells primed for rapid adhesion to collagen IV. Clin. Immunol. 105:247-58
134. De Fougerolles AR, Sprague AG, Nickerson-Nutter CL, Chi-Rosso G, Rennert PD, et al. 2000. Regulation of inflammation by collagen-binding integrins α1β1 and α2β1 in models of hypersensitivity and arthritis. J. Clin. Invest. 105:721-29
135. Fiorucci S, Mencarelli A, Palazzetti B, Sprague AG, Distrutti E, et al. 2002. Importance of innate immunity and collagen binding integrin α1β1 in TNBS-induced colitis. Immunity 17:769-80
136. 1 regulates intestinal inflammation in experimental colitis. J. Clin. Invest. 110:1773-82
137. Meharra EJ, Schön M, Hassett D, Parker C, Havran W, Gardner H. 2000. Reduced gut intraepithelial lymphocytes in VLA1 null mice. Cell. Immunol. 201:1-5
138. Dustin ML, De Fougerolles AR. 2001. Reprograming T cells: the role of extracellular matrix in coordination of T cell activation and migration. Curr. Opin. Immunol. 13:286-90
139. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1753-71
140. Henri S, Vremec D, Kamath A, Waithman J, Williams S, et al. 2001. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167:741-48
141. Salomon B, Cohen JL, Masurier C, Klatzmann D. 1998. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J. Immunol. 160:708-17
142. Ruedl C, Koebel P, Bachmann M, Hess M, Karjalainen K. 2000. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 165:4910-16
143. M290β7 by a major subpopulation of dendritic cells in mice. Eur. J. Immunol. 23:3365-68
144. Puig-Kroger A, Sanz-Rodriguez F, Longo N, Sanchez-Mateos P, Botella L, et al. 2000. Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells. J. Immunol. 165:4338-45
145. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, Van Vliet SJ, Van Duijnhoven GC, et al. 2000. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat. Immunol. 1:353-57
146. Brown KA, Bedford P, Macey M, McCarthy DA, LeRoy F, et al. 1997. Human blood dendritic cells: binding to vascular endothelium and expression of adhesion molecules. Clin. Exp. Immunol. 107:601-7
147. Ma J, Wang J-H, Guo Y-J, Sy M-S, Bigby M. 1994. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell. Immunol. 158:389-99
148. Xu H, Guan H, Zu G, Bullard D, Hanson J, et al. 2001. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur. J. Immunol. 31:3085-93
149. Price AA, Cumberbatch M, Kimber I, Ager A. 1997. α6 integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 186:1725-35
150. Shimizu Y. 2003. Disabling multiple integrins from the inside out. J. Clin. Invest. 111:23-24